- Risks associated with sunitinib use and monitoring to improve patient outcomes
-
Choi BS
- KMID: 1792008
- Korean J Intern Med.
- 2014 Jan;29(1):23-26.
- doi: 10.3904/kjim.2014.29.1.23
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea
-
Baek SH, Kim H, Lee J, Kim DK, Oh KH, Kim YS, Han JS, Kim TM, Lee SH, Joo KW
- KMID: 1792011
- Korean J Intern Med.
- 2014 Jan;29(1):40-48.
- doi: 10.3904/kjim.2014.29.1.40
BACKGROUND/AIMS: Sunitinib is an oral multitargeted tyrosine kinase inhibitor used mainly for the treatment of metastatic renal cell carcinoma. The renal adverse effects (RAEs) of sunitinib have not been investigated.... -
- CITED
-
- Close
- SHARE
-
- Close
